Insmed to Participate at November Investor Conferences
Nov 14, 2016 13:01 pm UTC| Business
BRIDGEWATER, N.J., Nov. 14, 2016 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported that the company will participate at...
Insmed to Participate at November Investor Conferences
Nov 14, 2016 13:01 pm UTC| Business
BRIDGEWATER, N.J., Nov. 14, 2016 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported that the company will participate at...
Nov 14, 2016 13:01 pm UTC| Business
NEW YORK, Nov. 14, 2016 -- The Wall Street Journal today launched a redesigned newspaper, showcasing the most compelling daily package of business, economic and financial news, complimented by incisive features and...
Nov 14, 2016 13:01 pm UTC| Business
NEW YORK, Nov. 14, 2016 -- The Wall Street Journal today launched a redesigned newspaper, showcasing the most compelling daily package of business, economic and financial news, complimented by incisive features and...
Nov 14, 2016 13:01 pm UTC| Business
-- CB 2679d/ISU304 Demonstrates Beneficial Effect in Hemophilia B Murine Models Using Subcutaneous Dosing -- -- Subcutaneous Phase 1/2 Proof-of-Concept Clinical Trial of High-Potency Factor IX CB 2679d/ISU304 in...
Nov 14, 2016 13:01 pm UTC| Business
-- CB 2679d/ISU304 Demonstrates Beneficial Effect in Hemophilia B Murine Models Using Subcutaneous Dosing -- -- Subcutaneous Phase 1/2 Proof-of-Concept Clinical Trial of High-Potency Factor IX CB 2679d/ISU304 in...
CoLucid Pharmaceuticals Provides SPARTAN Enrollment Update
Nov 14, 2016 13:01 pm UTC| Business
Comparison of 50 mg, 100 mg and 200 mg of lasmiditan oral tablets to placebo for the acute treatment of migraineOver 50% of the expected 2,968 migraine patients enrolled77% of patients enrolled to date have multiple...